![](/img/cover-not-exists.png)
PCN194 COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL FOR PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER IN ENGLAND
Harding, T., Dawson, H., Insinga, R., Topaloudi, V., Ejzykowicz, F., Zhang, Y.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.390
Date:
November, 2019
File:
PDF, 381 KB
2019